Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer.

@article{Hauns1999PhaseIS,
  title={Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer.},
  author={B. Hauns and B. Haering and S. K{\"o}hler and K. Mross and P. Robben-Bathe and C. Unger},
  journal={Arzneimittel-Forschung},
  year={1999},
  volume={49 12},
  pages={
          1030-4
        }
}
  • B. Hauns, B. Haering, +3 authors C. Unger
  • Published 1999
  • Medicine
  • Arzneimittel-Forschung
  • The aim of the study was to evaluate the efficacy and tolerability of as well as the quality of life under treatment with 5-fluorouracil (CAS 51-21-8, 5-FU) combined with parenteral GBE 761 ONC (i.e. the ginkgo biloba special extract EGb 761) in patients with pancreatic cancer. Forty-eight patients with locally or metastatic advanced pancreatic cancer were treated within a phase II study. The treatment was repeated every three weeks until progression. Response to therapy was evaluated after 2… CONTINUE READING